Publication | Closed Access

Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways

InflammationAnti-inflammatoryMlck/mlc2 PathwaysMedicineImmunologyGastroenterologyIntestinal BarrierGut BarrierAtractylodes OilMetabolomicsPharmacology